Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 4Recruiting 3Completed 3Not yet recruiting 2Unknown 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Venous Thromboembolism 1Stroke 1Skin Neoplasms 1Sarcoma 1Restless Legs Syndrome 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pituitary Neoplasms 1Parkinson Disease 1Odontogenic Cysts 1Multiple Sclerosis 1Migraine Disorders 1Localized Advanced Rectal Adenocarcinoma 1Keratosis, Actinic 1Inflammatory Bowel Diseases 1Hematoma 1Esophageal Neoplasms 1Epilepsy 1Dysbiosis 1Crohn Disease 1Colitis, Ulcerative 1Cognitive Dysfunction 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Brain Concussion 1Bone Neoplasms 1

Interventions

oxycodone-acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Enrolling by invitation × Skin Neoplasms × Clear all
NCT07575230 2026-05-11

Suzetrigine vs Norco-postoperative Mohs Pain

Baylor Research Institute

Phase 4 Enrolling by invitation
75 enrolled
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡